Published in Eur J Clin Invest on April 01, 1996
Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery (2001) 1.47
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer (2001) 1.10
Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients. J Neurosci Rural Pract (2011) 1.01
Sensitization and tolerization to brain antigens in stroke. Neuroscience (2008) 0.93
Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke. Indian J Clin Biochem (2011) 0.88
Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol (2007) 0.87
Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury. J Neurotrauma (2010) 0.84
Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis? Crit Care (2016) 0.80
Biochemical changes in the injured brain. World J Biol Chem (2017) 0.75
Prediction of Outcome in Diabetic Acute Ischemic Stroke Patients: A Hospital-Based Pilot Study Report. Ann Neurosci (2016) 0.75
Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke. J Med Life (2015) 0.75
Inflammation-induced reversible switch of the neuron-specific enolase promoter from Purkinje neurons to Bergmann glia. Sci Rep (2016) 0.75
Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax (1998) 3.86
Particulate air pollution and the blood. Thorax (1999) 3.29
Maternal plasma alpha-fetoprotein screening for fetal neural tube defects. Br J Obstet Gynaecol (1978) 3.20
Traits and selection strategies to improve root systems and water uptake in water-limited wheat crops. J Exp Bot (2012) 2.30
Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec (1998) 2.05
Maternal serum-alpha-fetoprotein measurements as an early indicator of low birth-weight. Lancet (1977) 1.97
Significance of elevated mid-trimester maternal plasma-alpha-fetoprotein values. Lancet (1979) 1.94
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology (1998) 1.72
Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. EMBO J (1990) 1.72
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
Neonatal secretion of gastrin and glucagon. Arch Dis Child (1974) 1.70
Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol (2001) 1.60
Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58
Untrained community help in the rehabilitation of stroke sufferers with language disorder. Br Med J (1978) 1.54
Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol (1995) 1.50
Neuropeptide variability in man. Eur J Clin Invest (2000) 1.45
Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur J Gastroenterol Hepatol (1998) 1.45
Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler (2004) 1.45
An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J Neurol Sci (2000) 1.40
Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J (2000) 1.39
Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988. Q J Med (1991) 1.39
Anaesthesia for magnetic resonance imaging: a survey of current practice in the UK and Ireland. Anaesthesia (2000) 1.39
Neuroendocrine tumors. A European view. Am J Med (1986) 1.29
Stimulation of gastrin release by catecholamines. Lancet (1972) 1.26
Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol) (2003) 1.26
The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985. Q J Med (1989) 1.25
Improvement of in-rumen digestibility of alfalfa forage by genetic manipulation of lignin O-methyltransferases. Transgenic Res (2001) 1.24
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. QJM (1998) 1.23
Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta (1973) 1.20
Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec (1994) 1.18
Respiratory acidosis in hypothermic myxoedema coma. Postgrad Med J (1967) 1.17
The quest for the inhibitory neurotransmitter in bovine tracheal smooth muscle. Q J Exp Physiol (1983) 1.16
Maturity onset diabetes mellitus: response to intensive dietary management. Br Med J (1975) 1.13
Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg (1996) 1.13
Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol (2003) 1.12
Violence towards junior doctors in accident and emergency departments. J Accid Emerg Med (1995) 1.12
Triglyceride metabolism in acute starvation: the role of secretin and glucagon. Eur J Clin Invest (1976) 1.10
Abnormalities of glucagon metabolism in untreated diabetes mellitus. Lancet (1972) 1.10
Effect of blood glucose on glucagon secretion in anesthetized dogs. Diabetes (1969) 1.09
Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J (1973) 1.08
The normal insulin response to glucose. The relationship between blood sugar and plasma insulin. Diabetologia (1967) 1.08
Cimetidine for duodenal ulceration in patients undergoing haemodialysis. Br Med J (1977) 1.07
Carbohydrate metabolism in duodenal ulcer patients. Gut (1967) 1.07
Quality of life in the first 100 days after suspected acute myocardial infarction--a suitable trial endpoint? J Epidemiol Community Health (1992) 1.07
Pancreatic glucagon release and sulphonylureas. Lancet (1969) 1.07
Carcinoma of the bronchus in the Yorkshire region of England 1976-1990: trends since 1984. Eur Respir J (1997) 1.07
Herniography for occult hernia and groin pain. Br J Surg (1994) 1.07
Animal model to study the relationship between immunoreactive gastrin and inflammatory arthritis. Nature (1974) 1.06
A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.06
Insulin control of glucagon release from insulin-deficient rat islets. Diabetes (1973) 1.05
Traumatic Brown-Séquard-plus syndrome. Arch Neurol (2001) 1.05
A glycoside-hydrolase inhibitor in treatment of dumping syndrome. Lancet (1979) 1.02
Glucagonoma syndrome demonstrating giant duodenal villi. Gut (1984) 1.02
Secretin: A new role for an old hormone. Lancet (1975) 1.02
Erythropoietin production in kidney tubular cells. Br J Haematol (1990) 1.00
Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin Ther (1995) 1.00
Relationship between physiological loss, performance decrement, and age in master athletes. J Gerontol A Biol Sci Med Sci (2001) 1.00
Isolation of glucagon-like immunoreactivity of gut by affinity chromatography on anti-glucagon antibodies coupled to sepharose 4 B. Biochim Biophys Acta (1973) 1.00
Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis. Am J Med (1972) 1.00
Anencephaly, spina bifida, and potato blight in the Edinburgh area. Lancet (1973) 0.99
Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. J Clin Endocrinol Metab (1969) 0.99
A double antibody immunoassay for glucagon. Diabetes (1968) 0.99
Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol (1987) 0.98
Glucagon clearance by the isolated perfused rat liver. Proc Soc Exp Biol Med (1968) 0.98
Serum immunoreactive gastrin in rheumatoid arthritis. Further observations on its identity, clinical specificity, and relationship to gastric function. Ann Rheum Dis (1976) 0.98
Cell-specific processing of chromogranin A in endocrine cells of the rat stomach. J Histochem Cytochem (2001) 0.98
The role of diencephalic pathology in human memory disorder. Evidence from a penetrating paranasal brain injury. Brain (1990) 0.97
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM (1999) 0.97
Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study. Histopathology (1991) 0.97
Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry (1998) 0.96
Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue. Vet Rec (2001) 0.96
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Diabetes (1996) 0.96
An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study. Mult Scler (2001) 0.95
The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem J (1994) 0.94
High circulating levels of glucagon and gastrin in anephric subjects. N Z Med J (1976) 0.94
Variable patterns of atrial natriuretic peptide secretion in man. Eur J Clin Invest (1994) 0.94
Antibodies to unconjugated synthetic and natural secretins. Horm Metab Res (1972) 0.94
Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett (1992) 0.93
Treatment of peptic ulcer in renal failure. Proc Eur Dial Transplant Assoc (1977) 0.93
Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest (1991) 0.93
Performance at altitude and angiotensin I-converting enzyme genotype. Eur J Appl Physiol (2004) 0.93
Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53. J Pathol (1998) 0.92
Effect of starvation and refeeding on serum immunoreactive glucagon and insulin levels. J Lab Clin Med (1968) 0.92
Role of insulin in glucose intolerance in uraemia. Lancet (1967) 0.92
Spastic syndrome in a Holstein bull: a histologic study. Vet Pathol (1987) 0.91